Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2021-12-08 Purchase | 2021-12-09 4:18 pm | Pyxis Oncology Inc. | PYXS | Cline Darren S Director | 10,000 | $9.3885 | $93,885 | 10,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-06-13 Option Award | 2024-06-17 8:15 pm | N/A 2034-06-13 | PLIANT THERAPEUTICS INC. | PLRX | Cline Darren S Director | 26,764 | $0 | 26,764 (Direct) | View |
2024-03-26 Option Award | 2024-03-28 4:33 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Cline Darren S Director | 35,219 | $0 | 251,405 (Direct) | View |
2023-06-16 Option Award | 2023-06-20 6:41 pm | N/A 2033-06-15 | IMPEL PHARMACEUTICALS INC | IMPL | Cline Darren S Director | 13,222 | $0 | 13,222 (Direct) | View |
2023-06-07 Option Award | 2023-06-08 5:09 pm | N/A 2033-06-07 | PLIANT THERAPEUTICS INC. | PLRX | Cline Darren S Director | 14,000 | $0 | 14,000 (Direct) | View |
2023-04-12 Option Award | 2023-04-14 4:58 pm | N/A 2033-04-11 | IMPEL PHARMACEUTICALS INC | IMPL | Cline Darren S Director | 20,013 | $0 | 20,013 (Direct) | View |
Ownership | 2023-04-13 6:10 pm | N/A N/A | IMPEL PHARMACEUTICALS INC | IMPL | Cline Darren S Director | 0 | $0 | 0 (Direct) | View |
2023-03-24 Option Award | 2023-03-28 4:41 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Cline Darren S Director | 139,355 | $0 | 216,186 (Direct) | View |
2023-03-06 Option Award | 2023-03-08 4:36 pm | N/A 2033-03-06 | PLIANT THERAPEUTICS INC. | PLRX | Cline Darren S Director | 22,000 | $0 | 22,000 (Direct) | View |
2022-03-31 Option Award | 2022-04-04 4:15 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Cline Darren S Director | 66,831 | $0 | 76,831 (Direct) | View |
2021-10-07 Option Award | 2021-10-12 7:47 pm | N/A 2031-10-07 | Pyxis Oncology Inc. | PYXS | Cline Darren S Director | 42,191 | $0 | 42,191 (Direct) | View |
Ownership | 2021-10-07 9:10 pm | N/A 2031-08-18 | Pyxis Oncology Inc. | PYXS | Cline Darren S Director | 0 | $0 | 15,725 (Direct) | View |
2021-05-05 Disposition | 2021-05-07 4:21 pm | N/A 2029-05-28 | GW PHARMACEUTICALS PLC | GWPH | Cline Darren S U.S. Chief Commercial Officer | 585,276 | $0 | 0 (Direct) | View |
2021-03-02 Option Award | 2021-03-04 9:05 pm | N/A N/A | GW PHARMACEUTICALS PLC | GWPH | Cline Darren S U.S. Chief Commercial Officer | 121,920 | $0 | 121,920 (Direct) | View |
2021-02-22 Option Award | 2021-02-24 6:53 pm | N/A N/A | GW PHARMACEUTICALS PLC | GWPH | Cline Darren S U.S. Chief Commercial Officer | 121,920 | $0 | 121,920 (Direct) | View |
2020-06-10 Equity Swap | 2020-06-10 11:15 am | N/A N/A | STEMLINE THERAPEUTICS INC | STML | Cline Darren S Director | 35,468 | $0 | 0 (Direct) | View |
2020-06-04 Option Award | 2020-06-08 8:00 pm | N/A N/A | GW PHARMACEUTICALS PLC | GWPH | Cline Darren S U.S. Chief Commercial Officer | 283,500 | $0 | 283,500 (Direct) | View |
2020-05-28 Exercise | 2020-05-29 8:00 pm | 2020-05-28 2020-05-28 | GW PHARMACEUTICALS PLC | GWPH | Cline Darren S U.S. Chief Commercial Officer | 7,356 | $0 | 5,556 (Direct) | View |
2020-05-28 Exercise | 2020-05-29 8:00 pm | N/A N/A | GW PHARMACEUTICALS PLC | GWPH | Cline Darren S U.S. Chief Commercial Officer | 7,356 | $0.0012 | 5,556 (Direct) | View |
2020-05-28 Tax Withholding | 2020-05-29 8:00 pm | N/A N/A | GW PHARMACEUTICALS PLC | GWPH | Cline Darren S U.S. Chief Commercial Officer | 1,800 | $10.54 | 5,556 (Direct) | View |